CenterWatch

Inflammatory Bowel Disease Clinical Trials

A listing of Inflammatory Bowel Disease medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter By:

 

Alabama

Huntsville Alabama 35802

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Mobile Alabama 36608

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Mobile Alabama 36608

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Mobile Alabama 36608

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Arizona

Phoenix Arizona 85054

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Scottsdale Arizona 85260

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Tucson Arizona 85712

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Tucson Arizona 85724

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Tucson Arizona 85712

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

View More ▼

Tucson Arizona 85710

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Arkansas

Little Rock Arkansas 72211

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Little Rock Arkansas 72205

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

North Little Rock Arkansas 72117

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Sherwood Arkansas 72120

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

California

UPDATED

Palo Alto California 94305

A Phase 2 clinical study for patients with Colitis, Ulcerative

Bakersfield California 93301

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Garden Grove California 92845

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

La Mirada California 90638

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Laguna Hills California 92653

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

View More ▼

Los Angeles California 90067

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Los Angeles California 90045

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Mission Hills California 91345

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Northridge California 91324

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Oceanside California 92056

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Oceanside California 92056

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Orange California 92868

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Palo Alto California 94304

Patients are needed to participate in a clinical research study evaluating fecal calprotectin level for the treatment of Inflammatory Bowel Disease or Irritable Bowel Syndrome (IBS)

San Carlos California 94070

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

San Diego California 92103

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

San Diego California 92103

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

San Diego California 92103

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

San Francisco California 94115

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

San Francisco California 94115

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

San Francisco California 94115

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Torrance California 90503

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Colorado

Denver Colorado 80045

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Littleton Colorado 80120

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Connecticut

UPDATED

New Haven Connecticut 06510

A Phase 2 clinical study for patients with Colitis, Ulcerative

Bristol Connecticut 06010

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Bristol Connecticut 06010

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Danbury Connecticut 06810

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Plainville Connecticut 06062

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Florida

UPDATED

Miami Florida 33136

A Phase 2 clinical study for patients with Colitis, Ulcerative

Boca Raton Florida 33428

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Boynton Beach Florida 33426

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Clearwater Florida 33756

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Coral Gables Florida 33173

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

View More ▼

Coral Springs Florida 33071

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Crystal River Florida 34429

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Deland Florida 32720

A clinical trial to evaluate treatments using Apremilast and Placebo for patients with Ulcerative Colitis